Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...

The medical device maker's adjusted earnings per share and revenue were more than expected, as sales of its cardiovascular products surged. Boston Scientific gave a mixed updated full-year forecast.

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Number of Hedge Fund Holders: 82 Boston Scientific Corporation (NYSE: BSX) is a leading global medical device manufacturer ...